By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.
A combination of insulin glargine and lixisenatide helps people with type 2 diabetes reach meal-time blood sugar targets better, according to a new study. The LixiLan-L trial investigated a ...
Tarja Stenvall is the general manager for the Diabetes and Cardiovascular Business Unit and UK Country Chair for Sanofi. The pharmaceutical company has an 85-year commitment to improving the ...
A combination insulin/GLP-1 agonist drug has shown greater efficacy in controlling type 2 diabetes. The results of the Sanofi drug iGlarLixi, formerly known as LixiLan, were unveiled at ...
Teams who have “improved services and outcomes” for people with diabetes have just one week to enter the Quality in Care Diabetes (QiC) awards. The programme recognises, rewards and ...
Submissions for this year’s prestigious Quality in Diabetes Care (QiC) awards have opened. The announcement was made during the Diabetes UK Professional Conference in Glasgow where several ...
People who use Insuman pre-filled pens and cartridges have been warned of a temporary supply shortage of the products. Sanofi, the company which makes the items, said the limited availability ...
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes